- Home
- PMEC vs VTVT Comparison
PMEC vs VTVT Comparison
Compare PMEC & VTVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PMEC
- VTVT
- Stock Information
- Founded
- PMEC 1984
- VTVT 2015
- Country
- PMEC Singapore
- VTVT United States
- Employees
- PMEC N/A
- VTVT N/A
- Industry
- PMEC
- VTVT Biotechnology: Pharmaceutical Preparations
- Sector
- PMEC
- VTVT Health Care
- Exchange
- PMEC Nasdaq
- VTVT Nasdaq
- Market Cap
- PMEC 56.9M
- VTVT 47.9M
- IPO Year
- PMEC 2023
- VTVT 2015
- Fundamental
- Price
- PMEC $1.87
- VTVT $19.76
- Analyst Decision
- PMEC
- VTVT Strong Buy
- Analyst Count
- PMEC 0
- VTVT 2
- Target Price
- PMEC N/A
- VTVT $35.50
- AVG Volume (30 Days)
- PMEC 244.2K
- VTVT 3.0K
- Earning Date
- PMEC 01-01-0001
- VTVT 11-11-2025
- Dividend Yield
- PMEC N/A
- VTVT N/A
- EPS Growth
- PMEC N/A
- VTVT N/A
- EPS
- PMEC N/A
- VTVT N/A
- Revenue
- PMEC $74,349,000.00
- VTVT $17,000.00
- Revenue This Year
- PMEC N/A
- VTVT N/A
- Revenue Next Year
- PMEC N/A
- VTVT N/A
- P/E Ratio
- PMEC N/A
- VTVT N/A
- Revenue Growth
- PMEC 2.52
- VTVT N/A
- 52 Week Low
- PMEC $0.54
- VTVT $12.62
- 52 Week High
- PMEC $1.89
- VTVT $26.99
- Technical
- Relative Strength Index (RSI)
- PMEC 62.47
- VTVT 71.89
- Support Level
- PMEC $1.76
- VTVT $15.79
- Resistance Level
- PMEC $1.88
- VTVT $21.01
- Average True Range (ATR)
- PMEC 0.15
- VTVT 0.96
- MACD
- PMEC 0.02
- VTVT 0.32
- Stochastic Oscillator
- PMEC 96.92
- VTVT 76.02
About PMEC Primech Holdings Ltd.
Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.
About VTVT vTv Therapeutics Inc.
vTv Therapeutics Inc is a clinical stage biopharmaceutical company focused on the development of orally administered treatments for metabolic and inflammatory diseases to minimize their long-term complications and improve the lives of patients. Its product pipeline include TTP399, TTP273, HPP737, HPP593, Azeliragon, HPP971, HPP3033, and TTP-RA.